ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences cash
Cash and short-term investments held at the end of each period.
ENDRA Life Sciences's cash was $1.74M at Jun 30, 2026. For fiscal 2025 it was $762.37K, down 76.4% from the year before. Over ten years it grew 44.6% a year on average. The highest annual figure on record is $9.46M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $762.37K | -76.4% |
| FY2024 | Dec 31, 2024 | $3.23M | +14.0% |
| FY2023 | Dec 31, 2023 | $2.83M | -42.0% |
| FY2022 | Dec 31, 2022 | $4.89M | -48.3% |
| FY2021 | Dec 31, 2021 | $9.46M | +30.9% |
| FY2020 | Dec 31, 2020 | $7.23M | +17.1% |
| FY2019 | Dec 31, 2019 | $6.17M | -4.6% |
| FY2018 | Dec 31, 2018 | $6.47M | +15.5% |
| FY2017 | Dec 31, 2017 | $5.60M | +3764.6% |
| FY2016 | Dec 31, 2016 | $144.95K | +657.8% |
| FY2015 | Dec 31, 2015 | $19.13K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.74M | -3.8% |
| Q1 FY2026 | Mar 31, 2026 | $356.46K | -82.7% |
| Q4 FY2025 | Dec 31, 2025 | $762.37K | -76.4% |
| Q3 FY2025 | Sep 30, 2025 | $794.04K | -83.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.81M | -71.7% |
| Q1 FY2025 | Mar 31, 2025 | $2.06M | +82.0% |
| Q4 FY2024 | Dec 31, 2024 | $3.23M | +14.0% |
| Q3 FY2024 | Sep 30, 2024 | $4.75M | +42.3% |
| Q2 FY2024 | Jun 30, 2024 | $6.40M | +32.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.13M | -51.8% |
| Q4 FY2023 | Dec 31, 2023 | $2.83M | -42.0% |
| Q3 FY2023 | Sep 30, 2023 | $3.33M | -58.4% |
| Q2 FY2023 | Jun 30, 2023 | $4.82M | -57.3% |
| Q1 FY2023 | Mar 31, 2023 | $2.36M | -67.0% |
| Q4 FY2022 | Dec 31, 2022 | $4.89M | -48.3% |
| Q3 FY2022 | Sep 30, 2022 | $8.02M | -32.0% |
| Q2 FY2022 | Jun 30, 2022 | $11.28M | -19.7% |
| Q1 FY2022 | Mar 31, 2022 | $7.13M | -57.7% |
| Q4 FY2021 | Dec 31, 2021 | $9.46M | +30.9% |
| Q3 FY2021 | Sep 30, 2021 | $11.79M | +210.9% |
| Q2 FY2021 | Jun 30, 2021 | $14.04M | +1776.0% |
| Q1 FY2021 | Mar 31, 2021 | $16.84M | +442.8% |
| Q4 FY2020 | Dec 31, 2020 | $7.23M | +17.1% |
| Q3 FY2020 | Sep 30, 2020 | $3.79M | +66.7% |
| Q2 FY2020 | Jun 30, 2020 | $748.56K | -67.0% |
| Q1 FY2020 | Mar 31, 2020 | $3.10M | -21.0% |
| Q4 FY2019 | Dec 31, 2019 | $6.17M | -4.6% |
| Q3 FY2019 | Sep 30, 2019 | $2.28M | +257.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.27M | +2.8% |
| Q1 FY2019 | Mar 31, 2019 | $3.93M | +24.6% |
| Q4 FY2018 | Dec 31, 2018 | $6.47M | +15.5% |
| Q3 FY2018 | Sep 30, 2018 | $637.12K | -90.9% |
| Q2 FY2018 | Jun 30, 2018 | $2.21M | -70.7% |
| Q1 FY2018 | Mar 31, 2018 | $3.15M | +2256.4% |
| Q4 FY2017 | Dec 31, 2017 | $5.60M | +3764.6% |
| Q3 FY2017 | Sep 30, 2017 | $6.98M | +9136.4% |
| Q2 FY2017 | Jun 30, 2017 | $7.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $133.68K | – |
| Q4 FY2016 | Dec 31, 2016 | $144.95K | – |
| Q3 FY2016 | Sep 30, 2016 | $75.54K | – |
See a number that looks wrong?